DOPE-PEG2000-EB1
DOPE-PEG2000-EB1 (DOPE-PEG2000-Mal-Cys-LIRLWSHLIHIWFQNRRLKWKKK) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the EB1 peptide (a penetratin analog). EB1 peptide is an endosomolytic agent that forms an amphipathic alpha helix upon protonation in endosomes, driving endosomal membrane permeabilization. DOPE-PEG2000-EB1 is used for intracellular delivery of nucleic acids (e.g., siRNA) and other macromolecular therapeutics.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
DOPE-PEG2000-EB1: functionalization of liposomes and nanoparticles for enhanced intracellular delivery of siRNA, nucleic acids, and macromolecular drugs, particularly to overcome the endosomal escape barrier.
Structural composition:
(1) DOPE; a fusogenic phospholipid with two oleoyl chains that anchors into lipid bilayers and promotes membrane destabilization and fusion under acidic conditions;
(2) PEG2000; a hydrophilic polymer that provides steric stabilization, reduces opsonization, and extends circulation time;
(3) EB1 peptide; a penetratin analog and endosomolytic agent that forms an amphipathic alpha helix upon protonation in early-to-late endosomes, permeabilizing endosomal membranes and enabling encapsulated cargo (e.g., siRNA) to escape into the cytosol for effective gene silencing.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
SMILES
[DOPE-PEG2000-EB1]
-
Synonyms
DOPE-PEG2000-Mal-Cys-LIRLWSHLIHIWFQNRRLKWKKK
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA interference technology
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing gene transcription or activating RNA degradation. This mechanism was discovered in plants in 1998 by Andrew Fire and Craig Mello. Today, this phenomenon can be observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)